MLYS · Mineralys Therapeutics, Inc. · Documents
$20.72
-0.76 (-3.52%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$1.90B
Shares
88.41M
Volume · Oct 23
161.3K
Avg daily vol (3M)
1.13M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-05-22 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| DEFA14A | — | 2024-04-09 | — | |
| ARS | — | 2024-04-09 | 2023-12-31 | |
| DEF 14A | — | 2024-04-09 | — | |
| 8-K | — | 2024-04-04 | 2024-03-29 | |
| S-3/A | — | 2024-03-29 | — | |
| S-3 | — | 2024-03-21 | — | |
| 10-K | — | 2024-03-21 | 2023-12-31 | |
| 8-K | — | 2024-03-21 | — | |
| 8-K | — | 2024-02-08 | 2024-02-07 | |
| 8-K | — | 2024-01-04 | — | |
| 8-K | — | 2023-12-22 | 2023-12-21 | |
| 8-K | — | 2023-11-13 | 2023-11-11 | |
| 10-Q | — | 2023-11-07 | 2023-09-30 | |
| 8-K | — | 2023-11-07 | — | |
| 8-K | — | 2023-11-02 | — | |
| 8-K | — | 2023-09-14 | 2023-09-12 | |
| 8-K | — | 2023-08-07 | — | |
| 10-Q | — | 2023-08-07 | 2023-06-30 | |
| 8-K | — | 2023-07-17 | — | |
| 8-K | — | 2023-05-15 | — | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 8-K | — | 2023-05-02 | — | |
| 8-K | — | 2023-03-22 | 2023-03-17 | |
| 10-K | — | 2023-03-15 | 2022-12-31 | |
| 8-K | — | 2023-03-15 | — | |
| 8-K | — | 2023-02-14 | — | |
| S-1/A | — | 2023-02-02 | — | |
| S-1 | — | 2023-01-18 | — |
Showing 51–81 of 81 filings
Key facts
CIK
1933414
CUSIP
603170101
13F (30d)
17 filings
17 filers
Visit website
Investor relations